Skip to content
← Compound profiles
Image for the Phytotherapy compound group
Phytotherapy

Cranberry

Vaccinium macrocarpon

Mechanism

Cranberry fruits contain proanthocyanidins with A-type linkage (PAC), to which an inhibition of bacterial adhesion (including P-fimbriated E. coli) to the urothelium is attributed in vitro and in human research. From this the traditional application in the area of the urinary tract is derived. In the horse the evidence is thin: controlled equine studies on urinary-tract endpoints are lacking, and the transferability of the human anti-adhesion data is not proven. The relevant sugar/fruit content of the berry is to be noted.

Cautions

  • · Mind the sugar/fructan content — avoid in EMS, PPID/Cushing or laminitis predisposition
  • · No substitute for veterinary clarification in case of urinary-tract symptoms
  • · Prefer a standardised extract; equine efficacy not proven

Sources

PMID:16055161Howell et al. 2005 (Phytochemistry) — A-Typ-Proanthocyanidine und Anti-Adhäsion uropathogener Bakterien
PMID:28635280Peron et al. 2017 (J Agric Food Chem) — Antiadhäsive Aktivität & Metabolomik nach Cranberry-Gabe (Rattenmodell)
Futtermittel-VO 767/2009VO (EG) 767/2009 — Deklaration als Ergänzungsfuttermittel

Usage note

This content is for information and education. It does not replace veterinary diagnosis or treatment. If your horse shows signs of illness, consult a veterinarian.

“Nothing forced can ever be beautiful.”
Xenophon · On Horsemanship (c. 365 BC)

Equiterna is an intermediary platform for equine knowledge, marketplace and tools — not a veterinary-medicines dealer, veterinary practice or pharmacy. Compound information is study-attributed and free of healing claims. Legal framework: Regulation (EU) 2019/6 / TAMG (DE/AT), Feed Regulation (EC) 767/2009, FEI Prohibited Substances List, HWG.